|
Search
Collections
Benchmarks
Upload document
Product
IGM2323
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Non-Hodgkin Lymphoma
Clinical trial
Treatment Guidelines for Expanded Access of Imvotamab (IGM-2323) in Patients With Relapsed/Refractory Non-Hodgkin Lymphomas From IGM-2323-001
Status:
